Share price 205.20GBp +0.00 (delayed by at least 15 mins)

The world's leading dedicated growth investor.

Our Growth Capital team provides financial and strategic support to established businesses with the potential for outstanding value growth, operating out of Europe, Asia and the Americas.

Typically we invest up to €150m in businesses with an enterprise value of up to and around €500m. We take a minority share to help a business to achieve growth ambitions, restructure shareholdings, release equity or change the balance of equity to debt. We provide flexible funding packages that may consist of a mixture of loan finance as well as equity funding – whatever is most suitable.

As an active partner:

  • it is your business to run. Our role is to support, advise, provide global insights and access to contacts.

As a shareholder:

  • your interests are the same as ours - profits, growth and sustainable success.

Once we have invested, we are committed to working in partnership; delivering our international network, our market insight and our energy to help build exceptional businesses.

We provide outstanding resources to entrepreneurs including:

  • in-depth industry insight and experience across six key global sectors

  • global perspective and network – with local teams in 13 countries across Europe, Asia and the Americas

Our partnership approach is fundamental to success.

3i Investment stories


Little Sheep

Little Sheep

Founded in 1999, Little Sheep is China’s leading hot pot restaurant chain with branches throughout Asia and internationally. It operate...
Find out more...


Labco

Labco

Labco is one of Europe’s leading laboratory diagnostics group, with market leading positions in France, Portugal and Spain. It also has...
Find out more...


Eyes on Growth - Edition 4

Latest news from 3i Growth Capital

Each business we partner with will typically have: an enterprise value of up to and around €500m; a management team of proven ability; a distinct position in the market and clear prospects for growth.

In return for our investment, we typically seek a minority shareholding (10-45%) and a seat on the board. We will only invest in a business when our interests are aligned with the majority shareholders. 

There are several ways that businesses use our investment funding and executive resources, including:

  • supporting growth – often by entering new territories, building production capacity or making strategic acquisitions;
  • restructuring shareholdings – to pass the business from one generation to the next, enabling the departure of a major shareholder or preparing it for a public listing;
  • releasing equity – where owners can unlock the equity they have built up over time by exchanging a portion of shareholding for cash whilst leaving the option of remaining a significant shareholder open;
  • changing the balance of debt and equity - to pursue market opportunities that might otherwise be unobtainable because of high levels of borrowing.


We invest from our own balance sheet. This enables us to invest for the longer term and adapt to changes in the business and market dynamics when required. Each investment we make will have a clear value-growth plan and a mutually agreed exit strategy.

3i Investment stories


Gain Capital

Gain Capital

GAIN Capital Group (GAIN) is a leading independent provider of online foreign exchange (forex) trading for individuals and institutions...
Find out more...


Quintiles Transnational

Quintiles Transnational

As a leading global provider of outsourced pharmaceutical services, Quintiles helps deliver new drugs and cures for the world’s most ch...
Find out more...


Eyes on Growth - Edition 4

Latest news from 3i Growth Capital

Anil Ahuja

Anil Ahuja

Head of Asia, South East Asia

Maite Ballester

Maite Ballester

Partner & Managing Director Spain, Spain

Tim Bartlett

Tim Bartlett

Manager, UK

Guillaume Basquin

Guillaume Basquin

Senior Associate, France

Alberto Bautista

Alberto Bautista

Senior Adviser - Healthcare, South East Asia

Mathieu Blanc

Mathieu Blanc

Director, France

Lars-Erik Blom

Lars-Erik Blom

Director, Sweden

Laura Boeck

Laura Boeck

Associate, Germany

Anna Cheung

Anna Cheung

Partner, China

Jonathan Crane

Jonathan Crane

Director, UK

Ying Cui

Ying Cui

Associate, China

Pieter de Jong

Pieter de Jong

Managing Director Benelux, Benelux

Pablo Echart

Pablo Echart

Director, UK

Markus Ehrler

Markus Ehrler

Banking Director, UK

Nikhil Gahrotra

Nikhil Gahrotra

Associate Director, India

Andreas Gold

Andreas Gold

Senior Associate, Germany

Miles Graham

Miles Graham

Director, Head of Active Partnership, UK

Gordon Hague

Gordon Hague

Director, UK

Ken Hanau

Ken Hanau

Managing Partner, 3i North America, North America

Edward Hanmer

Edward Hanmer

Principal, Brazil

Brian Hargreaves

Brian Hargreaves

Senior Advisor - Healthcare, UK

Neil Johnson

Sector Partner, UK

Anna Joseph

Anna Joseph

Director, UK

Tarun Joshi

Tarun Joshi

Associate Director, India

Claudia Kaupmannsennecke

Claudia Kaupmannsennecke

Director, Germany

Boris Kawohl

Boris Kawohl

Associate Director, Benelux

Richard Kilner

Richard Kilner

Partner, UK

Evan Klebe

Evan Klebe

Senior Associate, North America

Danny Koh

Danny Koh

Director, South East Asia

Olivier Le Gall

Olivier Le Gall

Partner, France

Tony Lissaman

Tony Lissaman

Chief Operating Officer, Private Equity, UK

Carlos Lopes

Carlos Lopes

Senior Associate, Brazil

Justin Maltz

Justin Maltz

Director, UK

Monish Mansukhani

Monish Mansukhani

Associate Director, South East Asia

Javier Martin

Javier Martin

Associate, France

Donald McDonough

Donald McDonough

Business Development Director, North America

Gianfranco Mottola

Gianfranco Mottola

Director, Italy

Sundip Murthy

Sundip Murthy

Principal, North America

Gabe Nadel

Gabe Nadel

Associate, North America

Christer Nilsson

Christer Nilsson

Director, Sweden

Anthony O'Carroll

Director, UK

Crevan O'Grady

Crevan O'Grady

Partner, North America

Andrew Olinick

Andrew Olinick

Principal, North America

Andre Perwas

Andre Perwas

Director, Germany

Agustin Pla

Agustin Pla

Partner, Spain

Stuart Quin

Stuart Quin

Associate Director, UK

Sainath Ramanathan

Sainath Ramanathan

Associate Director, India

Richard Relyea

Richard Relyea

Principal, North America

Denis Ribon

Denis Ribon

Partner, Managing Director, France

Miguel Segura

Miguel Segura

Senior Associate, Spain

Xuan Yong Soh

Xuan Yong Soh

Senior Associate, South East Asia

Dan Stern

Dan Stern

Senior Associate, UK

Paul Su

Senior Partner/Head of Greater China, China

Cindy Suo

Cindy Suo

Associate Director, China

Michael Tai

Michael Tai

Senior Associate, North America

John Thomson

John Thomson

Director, South East Asia

Alejo Vidal-Quadras

Alejo Vidal-Quadras

Associate Director, Spain

Vaibhav Vish

Vaibhav Vish

Associate, North America

Karen Wang

Karen Wang

Associate Director, China

Tony Wang

Tony Wang

Director, China

David Whileman

David Whileman

Partner, UK

Oliver Wong

Oliver Wong

Associate Director, South East Asia

Eric Xu

Eric Xu

Director, China

Albert Xu

Albert Xu

Partner, China

Guy Zarzavatdjian

Guy Zarzavatdjian

Managing Partner of Developing Markets, Head of Growth Fund, France

3i Investment stories


Labco

Labco

Labco is one of Europe’s leading laboratory diagnostics group, with market leading positions in France, Portugal and Spain. It also has...
Find out more...


Vijai Electricals

Vijai Electricals

Established in 1973, Vijai is among the largest players in India within the power transmission and distribution equipment industry. Vij...
Find out more...


Eyes on Growth - Edition 4

Latest news from 3i Growth Capital

Consumer

Consumer goods; retail; food & drink, leisure.

Find out more...

Healthcare

Pharmaceuticals & biotechnology; medical devices & technology; care service providers.

Find out more...